medigraphic.com
SPANISH

Acta Médica del Centro

ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

Acta Med Cent 2019; 13 (3)

Hemocromatosis tipo 1. Informe de caso

Santana HEE
Full text How to cite this article

Language: Spanish
References: 10
Page: 422-427
PDF size: 183.05 Kb.


Key words:

iron metabolism disorders, hemochromatosis type 1.

ABSTRACT

Introduction: Hemochromatosis type 1 is a genetic disease with great clinical and genetic heterogeneity, and an autosomal recessive inheritance pattern. Case report: The case of an 11-year-old male adolescent, son of a consanguineous couple is reported. The patient had been treated at the Provincial Genetics Center in Holguín since he was two years old due to growth problems, recurrent respiratory infections and gastrointestinal disorders with pancreatic insufficiency. Respiratory and liver failures were found, as well as cirrhosis, symptoms that were accompanied by a clinical sign: progressive hyperpigmentation of the skin. Different molecular studies were conducted for cystic fibrosis, alpha-1 antitrypsin deficiency and hemochromatosis. He was diagnosed, heterozygously, a mutation for alpha-1 antitrypsin Pi M/Z deficiency and another mutation for hemochromatosis type 1, H63D/. It was concluded he presented hemochromatosis type 1. Conclusions: It was possible to confirm the value of the clinical method to define complex cases which, due to their heterogeneity, cannot be defined molecularly with the technology that is still.


REFERENCES

  1. Cervera García IA, García Heredia M, Collazo Mesa T. Frecuencia de las mutaciones C282Y y H63D del gen HFE en pacientes con diagnóstico de deficiencia de alfa-1- antitripsina. Rev Med Electrón. 2016 Jun [citado 25 Mar 2019];38(3):361-369. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684- 18242016000300006&lng=es

  2. Cervera García I. Hemocromatosis tipo I. Patogenia y diagnóstico. Medisur [Internet]. 2012 Abr [citado 12 Jun 2019];10(2):128-135. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727- 897X2012000200008&lng=es

  3. Corrales Alonso S, Morales Díaz M, Estévez López M, Díaz Borroto AL, Álvarez Vega NP, Celestrín Tápanes H. Hemocromatosis herediataria Tipo I. Presentación de un caso. Rev Méd Electrón [Internet]. 2017 Ene-Feb [citado 25 Mar 2019];39(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684- 18242017000100011

  4. Brin M, Spiess J, Valverde M, Llambí L. Hemocromatosis hereditaria: debut como cirrosis compensada de diagnóstico incidental. Reporte de un caso y revisión del tema. Rev Urug Med Int [Internet]. 2019 Abr [citado 12 Jun 2019];4(1):40-48. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S2393- 67972019000100040&lng=es. http://dx.doi.org/10.26445/04.01.2

  5. Fernández-Delgado ND, Forrellat Barrios M, Valledor-Tristá R, Lavaut-Sánchez K, Cervera García I. Hemocromatosis hereditaria tipo I: a propósito de cuatro casos confirmados. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2014 Mar [citado 12 Jun 2019];30(1):59-67. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892014000100008&lng=es

  6. Zúñiga Cabrera A, Orera Clemente MA. Genética de las sobrecargas férricas. An Med Interna (Madrid) [Internet]. 2002 Abr [citado 12 Jun 2019];19(4):51-57. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212- 71992002000400010&lng=es

  7. Lantigua Cruz A. Introducción a la genética médica. Fenómenos que dificultan el reconocimiento de la segregación mendeliana. La Habana: Editorial Ciencias Médicas; 2004 .p.114-117.

  8. Toxqui L, Piero A, Courtois V, Bastida S, Sánchez-Muniz FJ, Vaquero MP. Deficiencia y sobrecarga de hierro: implicaciones en el estado oxidativo y la salud cardiovascular. Nutr Hosp [Internet]. 2010 Jun [citado 12 Jun 2019];25(3):350- 365. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212- 16112010000300003&lng=es

  9. Grosse SD, Gurrin LC, Bertalli NA, Allen KJ. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Genet Med [Internet]. 2017 Aug [citado 30 Oct 2018];20(4):383-389. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28771247

  10. Gharib AF, Karam RA, Pasha HF, Radwan MI, Elsawy WH. Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma. Gene [Internet]. 2011 Dec 10 [citado 30 Oct 2018];489(2):98-102. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21925577




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med Cent. 2019;13